Anna-Karin Sjögren, PhD, DABT, ERT

Director
AstraZeneca
Gothenburg, Vastra Gotaland, Sweden

Presentation(s):

• Addressing the Challenge of Drug-Induced Kidney Injury (DIKI) within Preclinical Drug Development (S01)

  Monday, November 18, 2024
  9:00 AM - 12:00 PM CT

• Utility of In Vitro Models for Predicting Drug-Induced Nephrotoxicity (S01-2)

  Monday, November 18, 2024
  9:15 AM - 9:45 AM CT